0.939978721307637		"SimpleArgument(Samuel D. "" Sam "" Waksal , Ph.D.,List([0, 32)))"	Relation(is,List([63, 65)))	SimpleArgument(former CEO of the biopharmaceutical company,List([66, 109)))	"Samuel D. ""Sam"" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems."
0.38089450366724514		SimpleArgument(September 8 , 1947 ),List([42, 62)))	Relation(is the founder of,List([63, 80)))	SimpleArgument(ImClone,List([81, 126)))	"Samuel D. ""Sam"" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems."
0.9286464928832516		"SimpleArgument(Samuel D. "" Sam "" Waksal , Ph.D.,List([0, 32)))"	Relation(is,List([63, 65)))	SimpleArgument(the founder of the biopharmaceutical company,List([66, 110)))	"Samuel D. ""Sam"" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems."
0.939978721307637		"SimpleArgument(Samuel D. "" Sam "" Waksal , Ph.D.,List([0, 32)))"	Relation(born,List([37, 41)))	TemporalArgument(September 8,List([42, 53)))	"Samuel D. ""Sam"" Waksal, Ph.D., (born September 8, 1947) is the founder and former CEO of the biopharmaceutical company ImClone Systems."
0.7900566639584307		SimpleArgument(Kadmon Pharmaceuticals,List([22, 44)))	Relation(was financed with private commenced operations in New York City in,List([51, 63), [64, 114), [115, 117)))	TemporalArgument(2010,List([118, 122)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.9277724913494431		SimpleArgument(Kadmon Pharmaceuticals,List([22, 44)))	Relation(was financed with,List([51, 63), [64, 68)))	SimpleArgument(private commenced operations in New York City,List([69, 114)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.7107293693420784		SimpleArgument(Kadmon Pharmaceuticals,List([22, 44)))	Relation(was financed in,List([51, 63), [85, 87)))	TemporalArgument(2010,List([88, 92)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.4978219019954182		SimpleArgument(Waksal,List([0, 2)))	Relation(is also,List([3, 10)))	SimpleArgument(the CEO of Kadmon Pharmaceuticals,List([11, 44)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.8341272337555721		SimpleArgument(the founder of Kadmon Pharmaceuticals,List([11, 48)))	Relation(was financed with private commenced operations in New York City in,List([55, 67), [68, 118), [119, 121)))	TemporalArgument(2010,List([122, 126)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.9449486126097173		SimpleArgument(the founder of Kadmon Pharmaceuticals,List([11, 48)))	Relation(was financed with,List([55, 67), [68, 72)))	SimpleArgument(private commenced operations in New York City,List([73, 118)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.7665312004125777		SimpleArgument(the founder of Kadmon Pharmaceuticals,List([11, 48)))	Relation(was financed in,List([55, 67), [89, 91)))	TemporalArgument(2010,List([92, 96)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.4978219019954182		SimpleArgument(Waksal,List([0, 2)))	Relation(is also,List([3, 10)))	SimpleArgument(the founder of Kadmon Pharmaceuticals,List([11, 48)))	He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010.
0.9180804252893389		SimpleArgument(ImClone,List([23, 34)))	Relation(to develop,List([35, 45)))	SimpleArgument(the landmark cancer drug Erbitux,List([46, 78)))	At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab).
0.9529384246512104		SimpleArgument(Waksal,List([12, 18)))	Relation(led the company At,List([0, 2), [19, 26), [27, 34)))	SpatialArgument(ImClone,List([3, 10)))	At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab).
0.9324144673478683		SimpleArgument(Waksal,List([12, 18)))	Relation(led the company to,List([19, 22), [23, 34), [35, 37)))	SimpleArgument(develop the landmark cancer drug Erbitux,List([38, 78)))	At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab).
0.9383119524695255		SimpleArgument(Waksal,List([12, 18)))	Relation(led,List([19, 22)))	SimpleArgument(ImClone,List([23, 34)))	At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux (cetuximab).
0.9166044900803317		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around improper communications with family members During,List([0, 6), [126, 178), [179, 186)))	TemporalArgument(the course of its review process with Drug Administration,List([7, 64)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9166044900803317		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around improper communications with personal friends During,List([0, 6), [126, 180), [181, 188)))	TemporalArgument(the course of its review process with Drug Administration,List([7, 64)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9166044900803317		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around improper communications with family members During,List([0, 6), [126, 178), [179, 186)))	TemporalArgument(the course of its review process with Food Administration,List([7, 64)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9064683704715875		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around,List([126, 135), [136, 142)))	SimpleArgument(improper communications with family members,List([143, 186)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9197759696552441		SimpleArgument(Waksal,List([73, 79)))	Relation(became involved in an insider trading scandal,List([80, 86), [87, 125)))	TemporalArgument(revolving around improper communications with family members,List([126, 186)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9166044900803317		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around improper communications with personal friends During,List([0, 6), [126, 180), [181, 188)))	TemporalArgument(the course of its review process with Food Administration,List([7, 64)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9064683704715875		SimpleArgument(Waksal,List([73, 79)))	Relation(revolving around,List([126, 135), [136, 142)))	SimpleArgument(improper communications with personal friends,List([143, 188)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9064683704715875		SimpleArgument(Waksal,List([73, 79)))	Relation(involved in,List([87, 95), [96, 98)))	SimpleArgument(an insider trading scandal,List([99, 125)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9197759696552441		SimpleArgument(Waksal,List([73, 79)))	Relation(became involved in an insider trading scandal,List([80, 86), [87, 125)))	TemporalArgument(revolving around improper communications with personal friends,List([126, 188)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.9197759696552441		SimpleArgument(Waksal,List([73, 79)))	Relation(became,List([80, 86)))	SimpleArgument(involved in an insider trading scandal,List([87, 125)))	During the course of its review process with Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members.
0.45170382506656653		SimpleArgument(Waksal,List([0, 2)))	Relation(served time in,List([3, 9), [10, 14), [15, 17)))	SpatialArgument(federal prison,List([18, 32)))	He was convicted of several securities violations, served time in federal prison, and was released.
0.45170382506656653		SimpleArgument(Waksal,List([0, 2)))	Relation(served,List([3, 9)))	SimpleArgument(time,List([10, 14)))	He was convicted of several securities violations, served time in federal prison, and was released.
0.45170382506656653		SimpleArgument(Waksal,List([0, 2)))	Relation(was convicted of,List([3, 16), [17, 19)))	SimpleArgument(several securities violations,List([20, 49)))	He was convicted of several securities violations, served time in federal prison, and was released.
